1Garcia RL,Coltrera MD,Gown AM.Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in fixed, embedded tissues:comparison with flow cytometric analysis[].American Journal of Pathology.1988
2Krane JF,Murphy DP,Gottieb AB,et al.Increased dermal expression of platelet- derived growth factor receptors in growth- activated skin wounds and psoriasis[].Journal of Investigative Dermatology.1991
4Marks R, Barton SP, Shuttleworth D, et al. Assessment of disease progress in psoriasis. Arch Dennatol 1989; 125(2) :235 - 240.
5Picker LJ, Kisnimoto TK, Smith CW. ELAM- 1 is an adhesion molecule for skin - homing T cells. Nature 1991 ;349:796.
6Onuma S. Immunohistochemical stukies of infiltrating cells in early and chronic of psoriasis. Dermatol 1994;21:223.
7Krane JF, Murphy DP, Gottheb AB, et al. Increased dermal expression of platelet - derived growth factor receptors in growth - activated skin wounds and psoriasis. J Invest Dermatol 1991 ;96:983- 986.
8Ansel JC, Tiesman JP, Olerud JE, ct al. Human keratinocytes are a major source of cutaneous platelet - derived growth factor. J Clin Invest 1993;92:671 - 678.
9Bos JD, Rie MA, Teunissen MB, et al. Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005;152:1098- 1107.
10Fleischmajer R, Kuroda K, Hazan R, et al.Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol, 2000, 115: 771-777.
